Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Development of a novel dual JAK/Src kinase inhibitor

07.01.2014
Inhibitors of both JAK and Src kinases represent promising targets for cancer therapeutics because of the central importance of these kinases in tumor cell proliferation and survival.

Furthermore, in cancer cells activation of JAK has been reported as a compensatory effect in response to Src inhibitor exposure. This implies simultaneous inhibition of both kinases could have a synergy of anti-cancer effects compared to an agent that inhibits one or the other kinases.

The research article by Liu et al describes MLS-2384 which is a synthetic derivative of amarine natural product, 6-bromoindirubin-3Œ-oxime. MLS-2384 exhibits a dual JAK/Src kinase inhibitory activity, blocks downstream signaling into the STAT3 pathway, and has anti-cancer activity in various human cancer cell lines.

These findings have important clinical implications for understanding the mechanisms of action of bromoindirubin derivatives.

The findings also indicate that this new 6-bromoindirubin derivative, MLS-2384, has potential as an anti-tumor therapeutic agent targeting JAK and Src kinases upstream of STAT3 in a wide variety of human cancer cells.

For the full report by Liu et al. in Cancer Biology & Therapy, visit the following link: https://www.landesbioscience.com/journals/cbt/article/26721/relevant and high-impact original research with a special focus on the

Published by Landes Bioscience since 2002, Cancer Biology & Therapy publishes molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. Established in 2002, Landes Bioscience is an Austin, Texas-based publisher of biology research journals and books.

Andrew Thompson | EurekAlert!
Further information:
http://www.landesbioscience.com

More articles from Life Sciences:

nachricht DNA survives critical entry into Earth’s atmosphere
27.11.2014 | Universität Zürich

nachricht Tremendous progress in the development of skin stem cell treatments for butterfly children
27.11.2014 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

Regional economic cooperation in Central Asia

21.11.2014 | Event News

Educating the Ecucators

13.11.2014 | Event News

36th Annual IATUL Conference 2015: Call for papers and posters

12.11.2014 | Event News

 
Latest News

Tremendous progress in the development of skin stem cell treatments for butterfly children

27.11.2014 | Life Sciences

DNA survives critical entry into Earth’s atmosphere

27.11.2014 | Life Sciences

Gesture and multi-touch operation of machinery and plant – on a 15" display

27.11.2014 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>